Home
Contact Us
How to Cite
Get Newsletter
Become a Member
Login
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
Research News
Drug News
Conference News
AD Hypotheses
AlzSWAN
Current Hypotheses
Hypothesis Factory
Forums
Live Discussions
Virtual Conferences
Interviews
Enabling Technologies
Workshops
Research Tools
Compendia
AlzGene
AlzRisk
Antibodies
Biomarkers
Mutations
Protocols
Research Models
Video Gallery
Resources
Bulletin Boards
Conference Calendar
Grants
Jobs
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Companies
Tutorial
Drugs in Clinical Trials
About Alzheimer's
FAQs
Diagnosis
Clinical Guidelines
Tests
Brain Banks
Treatment
Drugs and Therapies
Caregiving
Patient Care
Support Directory
AD Experiences
Member Directory
Researcher Profiles
Institutes and Labs
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Home
:
News
News
News Search
Invalid News ID: 332
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Del.icio.us
Digg
Facebook
Google
Newsvine
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Most E-mailed
Most Commented
Last 7 Days
Last 30 Days
Not Seeing Eye to Eye: Do Lenses Accumulate Aβ?
Gammagard™ Misses Endpoints in Phase 3 Trial
Guidelines at Nature Aim to Stem Tide of Irreproducibility
Paper Alert: Antisense Oligonucleotide Therapy Safe for ALS?
New Assays for Aβ Oligomers in CSF Claim Femtogram Sensitivity
Not Seeing Eye to Eye: Do Lenses Accumulate Aβ?
NIH Funds Four Clinical Trials in ADCS Renewal
As DIAN’s Scope Widens, Funding Narrows
Exercising Brain or Body: Both Seem to Help a Bit
Parkinson’s Gene Increases Risk of Dementia
Gammagard™ Misses Endpoints in Phase 3 Trial
Endocytosis Pulls α-Secretase From Synapses
Guidelines at Nature Aim to Stem Tide of Irreproducibility
Stem Cells Treat Epileptic Symptoms in Mice
Not Seeing Eye to Eye: Do Lenses Accumulate Aβ?
Gammagard™ Misses Endpoints in Phase 3 Trial
Endocytosis Pulls α-Secretase From Synapses
As DIAN’s Scope Widens, Funding Narrows
Does Progranulin Play Both Sides in AD and FTD?
Guidelines at Nature Aim to Stem Tide of Irreproducibility
Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum
Terms of Use
How to Cite
Privacy Policy
Disclaimer
Disclosure
Copyright